YAP1 and non-small cell lung carcinoma: Given previous reports of elevated YAP1 in osimertinib-resistant NSCLC [9], we analyzed GSE130160 data from the GEO database and found YAP1 expression significantly upregulated in resistant tissues (Fig. 1A), suggesting its potential critical role in osimertinib resistance.